152338936
commented on
$Alternus Clean Energy (ALCE.US)$ what with the rise today?
1
152338936
liked
$Interactive Strength (TRNR.US)$
Interactive Strength Inc. (Nasdaq:TRNR) Drives CLMBR Growth in Saudi Arabia With Multiple Installations Across Armah Sports Group's B_FIT brand
3 minutes ago, 4:00 AM PST
Via AccessWire
• Armah Sports Group is a leading operator in Saudi Arabia, with twelve locations across two brands and additional concepts in development
• CLMBRs are being installed in three of Armah Sports Group's B_FIT nine locations, with a further roll out being planned in the portfoli...
Interactive Strength Inc. (Nasdaq:TRNR) Drives CLMBR Growth in Saudi Arabia With Multiple Installations Across Armah Sports Group's B_FIT brand
3 minutes ago, 4:00 AM PST
Via AccessWire
• Armah Sports Group is a leading operator in Saudi Arabia, with twelve locations across two brands and additional concepts in development
• CLMBRs are being installed in three of Armah Sports Group's B_FIT nine locations, with a further roll out being planned in the portfoli...
3
152338936
liked
$Interactive Strength (TRNR.US)$ Interactive Strength Inc. (Nasdaq:TRNR) Drives CLMBR Growth in Saudi Arabia With Multiple Installations Across Armah Sports Group's B_FIT Brand
Accesswire· Armah Sports Group is a leading operator in Saudi Arabia, with twelve locations across two brands and additional concepts in development
CLMBRs are being installed in three of Armah Sports Group's B_FIT nine locations, with a further roll out being planned in the portfolio
The Saudi Arabia fitness market ...
Accesswire· Armah Sports Group is a leading operator in Saudi Arabia, with twelve locations across two brands and additional concepts in development
CLMBRs are being installed in three of Armah Sports Group's B_FIT nine locations, with a further roll out being planned in the portfolio
The Saudi Arabia fitness market ...
2
3
$Quhuo (QH.US)$ this sh$t seems will never recover
152338936
liked and commented on
$Cingulate (CING.US)$
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
Positive
Working capital increased by $19.5M from December 2023
Raised $12.5M in capital during Q3 2024
Net loss decreased by 46% YoY to $3.2M
R&D expenses reduced by $2.5M YoY
Secured European patents for CTx-1301 in up to 30 territories
Regained Nasdaq compliance with $1.00 minimum bid requirement
Negative
Accumulated deficit increa...
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
Positive
Working capital increased by $19.5M from December 2023
Raised $12.5M in capital during Q3 2024
Net loss decreased by 46% YoY to $3.2M
R&D expenses reduced by $2.5M YoY
Secured European patents for CTx-1301 in up to 30 territories
Regained Nasdaq compliance with $1.00 minimum bid requirement
Negative
Accumulated deficit increa...
2
4